Researchers at the Scripps Research Institute in the United States have innovated a groundbreaking microchip technology that reveals the intricate interactions between antibodies and viruses in as little as 90 minutes, utilizing just a 4-microliter blood sample. This pioneering approach offers swift and accurate data to bolster vaccine development and antibody research.